UTHEALTH HOME    ABOUT SBMI    A-Z    WEBMAIL    INSIDE THE UNIVERSITY
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use
Center for Computational Systems Medicine
leaf

Kinase Fusion Gene Summary

leaf

Kinase Fusion Gene Sample Information

leaf

Kinase Fusion ORF Analysis

leaf

Kinase Fusion Amino Acid Sequences

leaf

Multiple Sequence Alignment of All Fusion Protein Isoforms

leaf

Kinase Fusion Protein Functional Features

leaf

Kinase Fusion Protein Structures

leaf

Comparison of Fusion Protein Isoforms

leaf

Comparison of Fusion Protein Sequences/Structures with Known Sequences/Structures from PDB

leaf

pLDDT Scores and Difference Analysis of pLDDT Scores Between the Active Sites (Best) and Non-Active Sites.

leaf

Ramachandran Plot of Kinase Fusion Protein Structure

leaf

Potential Active Site Information

leaf

Virtual Screening Results

leaf

Kinase-Substrate Information

leaf

Related Drugs with This Kinase Fusion Protein

leaf

Related Disease with This Kinase Fusion Protein

leaf

Clinical Trials of the Found Drugs/Small Molecules

Kinase Fusion Gene:HIPK2_BRAF

Kinase Fusion Protein Summary

check button Kinase Fusion gene summary
Kinase Fusion partner gene informationKinase Fusion gene name: HIPK2_BRAF
KinaseFusionDB ID: KFG2686
FusionGDB2.0 ID: KFG2686
HgeneTgene
Gene symbol

HIPK2

BRAF

Gene ID

28996

673

Gene namehomeodomain interacting protein kinase 2B-Raf proto-oncogene, serine/threonine kinase
SynonymsPRO0593B-RAF1|B-raf|BRAF-1|BRAF1|NS7|RAFB1
Cytomap

7q34

7q34

Type of geneprotein-codingprotein-coding
Descriptionhomeodomain-interacting protein kinase 2hHIPk2serine/threonine-protein kinase B-raf94 kDa B-raf proteinB-Raf proto-oncogene serine/threonine-protein kinase (p94)B-Raf serine/threonine-proteinmurine sarcoma viral (v-raf) oncogene homolog B1proto-oncogene B-Rafv-raf murine sarcoma viral oncogene
Modification date2024031720240416
UniProtAcc

Q9H2X6

P15056

Ensembl transtripts involved in fusion geneENST idsENST00000342645, ENST00000406875, 
ENST00000428878, 		ENST00000288602, 
Context (manual curation of fusion genes in KinaseFusionDB)

PubMed: HIPK2 [Title/Abstract] AND BRAF [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)HIPK2(139297947)-BRAF(140449218), # samples:1
check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneHIPK2

GO:0006468

protein phosphorylation

19448668

HgeneHIPK2

GO:0018105

peptidyl-serine phosphorylation

33591310

HgeneHIPK2

GO:0030330

DNA damage response, signal transduction by p53 class mediator

14647468

HgeneHIPK2

GO:0045766

positive regulation of angiogenesis

19046997

HgeneHIPK2

GO:0060395

SMAD protein signal transduction

12874272

TgeneBRAF

GO:0000165

MAPK cascade

18567582|29433126

TgeneBRAF

GO:0006468

protein phosphorylation

17563371

TgeneBRAF

GO:0007173

epidermal growth factor receptor signaling pathway

18567582

TgeneBRAF

GO:0010828

positive regulation of glucose transmembrane transport

23010278

TgeneBRAF

GO:0033138

positive regulation of peptidyl-serine phosphorylation

19667065

TgeneBRAF

GO:0043066

negative regulation of apoptotic process

19667065

TgeneBRAF

GO:0070374

positive regulation of ERK1 and ERK2 cascade

22065586

TgeneBRAF

GO:0071277

cellular response to calcium ion

18567582

TgeneBRAF

GO:0090150

establishment of protein localization to membrane

23010278


check buttonKinase Fusion gene breakpoints across HIPK2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonKinase Fusion gene breakpoints across BRAF (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Kinase Fusion Gene Sample Information

check buttonKinase Fusion gene information.
check button Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceSampleHgeneHchrHbpTgeneTchrTbp
ChimerDB4TCGA-VQ-A92DHIPK2chr7

139297947

BRAFchr7

140449218



Top

Kinase Fusion ORF Analysis


check buttonKinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB.
HenstTenstHgeneHchrHbpTgeneTchrTbpSeq length
(transcript)		Seq length
(amino acids)
ENST00000406875ENST00000288602HIPK2chr7139297947BRAFchr71404492182766850

Top

Kinase Fusion Amino Acid Sequences


check button For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq

>ENST00000406875_ENST00000288602_HIPK2_chr7_139297947_BRAF_chr7_140449218_length(amino acids)=850
MAPVYEGMASHVQVFSPHTLQSSAFCSVKKLKIEPSSNWDMTGYGSHSKVYSQSKNIPLSQPATTTVSTSLPVPNPSLPYEQTIVFPGST
GHIVVTSASSTSVTGQVLGGPHNLMRRSTVSLLDTYQKCGLKRKSEEIENTSSVQIIEEHPPMIQNNASGATVATATTSTATSKNSGSNS
EGDYQLVQHEVLCSMTNTYEVLEFLGRGTFGQVVKCWKRGTNEIVAIKILKNHPSYARQGQIEVSILARLSTESADDYNFVRAYECFQHK
NHTCLVFEMLEQNLYDFLKQNKFSPLPLKYIRPVLQQVATALMKLKSLGLIHADLKPENIMLVDPSRQPYRVKVIDFGSASHVSKAVCST
YLQSRYYRAPEIILGLPFCEAIDMWSLGCVIAELFLGWPLYPGASEYDQIRYISQTQGLPAEYLLSAGTKTTRFFNRDTDSPYPLWRLKT
PDDHEAETGIKSKEARKYIFNCLDDMAQVNMTTDLEGSDMLVEKADRREFIDLLKKMLTIDADKRITPIETLNHPFVTMTHLLDFPHSTH
VKSCFQNMEICKRRVNMYDTVNQSKTPFITHVAPSTSTNLTMTFNNQLTTVHNQAPSSTSATISLANPEVSILNYPSTLYQPSAASMAAV
AQRSMPLQTGTAQICARPDPFQQALIVCPPGFQGLQASPSKHAGYSVRMENAVPIVTQAPGAQPLQIQPGLLAQAPEVIRMQDKNPYSFQ
SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR

--------------------------------------------------------------

Multiple Sequence Alignment of All Fusion Protein Isoforms



Top

Kinase Fusion Protein Functional Features


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr7:139297947/chr7:140449218)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
HIPK2

Q9H2X6

BRAF

P15056

FUNCTION: Serine/threonine-protein kinase involved in transcription regulation, p53/TP53-mediated cellular apoptosis and regulation of the cell cycle. Acts as a corepressor of several transcription factors, including SMAD1 and POU4F1/Brn3a and probably NK homeodomain transcription factors. Phosphorylates PDX1, ATF1, PML, p53/TP53, CREB1, CTBP1, CBX4, RUNX1, EP300, CTNNB1, HMGA1, ZBTB4 and DAZAP2. Inhibits cell growth and promotes apoptosis through the activation of p53/TP53 both at the transcription level and at the protein level (by phosphorylation and indirect acetylation). The phosphorylation of p53/TP53 may be mediated by a p53/TP53-HIPK2-AXIN1 complex. Involved in the response to hypoxia by acting as a transcriptional co-suppressor of HIF1A. Mediates transcriptional activation of TP73. In response to TGFB, cooperates with DAXX to activate JNK. Negative regulator through phosphorylation and subsequent proteasomal degradation of CTNNB1 and the antiapoptotic factor CTBP1. In the Wnt/beta-catenin signaling pathway acts as an intermediate kinase between MAP3K7/TAK1 and NLK to promote the proteasomal degradation of MYB. Phosphorylates CBX4 upon DNA damage and promotes its E3 SUMO-protein ligase activity. Activates CREB1 and ATF1 transcription factors by phosphorylation in response to genotoxic stress. In response to DNA damage, stabilizes PML by phosphorylation. PML, HIPK2 and FBXO3 may act synergically to activate p53/TP53-dependent transactivation. Promotes angiogenesis, and is involved in erythroid differentiation, especially during fetal liver erythropoiesis. Phosphorylation of RUNX1 and EP300 stimulates EP300 transcription regulation activity. Triggers ZBTB4 protein degradation in response to DNA damage. In response to DNA damage, phosphorylates DAZAP2 which localizes DAZAP2 to the nucleus, reduces interaction of DAZAP2 with HIPK2 and prevents DAZAP2-dependent ubiquitination of HIPK2 by E3 ubiquitin-protein ligase SIAH1 and subsequent proteasomal degradation (PubMed:33591310). Modulates HMGA1 DNA-binding affinity. In response to high glucose, triggers phosphorylation-mediated subnuclear localization shifting of PDX1. Involved in the regulation of eye size, lens formation and retinal lamination during late embryogenesis. {ECO:0000269|PubMed:11740489, ECO:0000269|PubMed:11925430, ECO:0000269|PubMed:12851404, ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:14678985, ECO:0000269|PubMed:17018294, ECO:0000269|PubMed:17960875, ECO:0000269|PubMed:18695000, ECO:0000269|PubMed:18809579, ECO:0000269|PubMed:19015637, ECO:0000269|PubMed:19046997, ECO:0000269|PubMed:19448668, ECO:0000269|PubMed:20307497, ECO:0000269|PubMed:20573984, ECO:0000269|PubMed:20637728, ECO:0000269|PubMed:20980392, ECO:0000269|PubMed:21192925, ECO:0000269|PubMed:22825850, ECO:0000269|PubMed:33591310}.FUNCTION: Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus (Probable). Phosphorylates MAP2K1, and thereby activates the MAP kinase signal transduction pathway (PubMed:21441910, PubMed:29433126). Phosphorylates PFKFB2 (PubMed:36402789). May play a role in the postsynaptic responses of hippocampal neurons (PubMed:1508179). {ECO:0000269|PubMed:1508179, ECO:0000269|PubMed:21441910, ECO:0000269|PubMed:29433126, ECO:0000269|PubMed:36402789, ECO:0000305}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

* Minus value of BPloci means that the break pointn is located before the CDS.

check button - Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt).
677704
PartnerHgeneeneHbpTgeneeneTbpENSTBPexonTotalExonProtein feature lociBPlociTotalLenFeatureNote
HgeneHIPK2139297947BRAF140449218ENST00000406875915199_52711172DomainNote=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159
HgeneHIPK2139297947BRAF140449218ENST00000406875915199_52711199DomainNote=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159


check button - Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt).
PartnerHgeneeneHbpTgeneeneTbpENSTBPexonTotalExonProtein feature lociBPlociTotalLenFeatureNote


Top

Kinase Fusion Protein Structures

check button CIF files of the predicted kinase fusion proteins
* Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format.
Kinase Fusion protein CIF link (fusion AA seq ID in KinaseFusionDB)HenstTenstHgeneHchrHbpTgeneTchrTbpAA seqLen(AA seq)
PDB file >>>132_HIPK2_BRAFENST00000406875ENST00000288602HIPK2chr7139297947BRAFchr7140449218
MAPVYEGMASHVQVFSPHTLQSSAFCSVKKLKIEPSSNWDMTGYGSHSKVYSQSKNIPLSQPATTTVSTSLPVPNPSLPYEQTIVFPGST
GHIVVTSASSTSVTGQVLGGPHNLMRRSTVSLLDTYQKCGLKRKSEEIENTSSVQIIEEHPPMIQNNASGATVATATTSTATSKNSGSNS
EGDYQLVQHEVLCSMTNTYEVLEFLGRGTFGQVVKCWKRGTNEIVAIKILKNHPSYARQGQIEVSILARLSTESADDYNFVRAYECFQHK
NHTCLVFEMLEQNLYDFLKQNKFSPLPLKYIRPVLQQVATALMKLKSLGLIHADLKPENIMLVDPSRQPYRVKVIDFGSASHVSKAVCST
YLQSRYYRAPEIILGLPFCEAIDMWSLGCVIAELFLGWPLYPGASEYDQIRYISQTQGLPAEYLLSAGTKTTRFFNRDTDSPYPLWRLKT
PDDHEAETGIKSKEARKYIFNCLDDMAQVNMTTDLEGSDMLVEKADRREFIDLLKKMLTIDADKRITPIETLNHPFVTMTHLLDFPHSTH
VKSCFQNMEICKRRVNMYDTVNQSKTPFITHVAPSTSTNLTMTFNNQLTTVHNQAPSSTSATISLANPEVSILNYPSTLYQPSAASMAAV
AQRSMPLQTGTAQICARPDPFQQALIVCPPGFQGLQASPSKHAGYSVRMENAVPIVTQAPGAQPLQIQPGLLAQAPEVIRMQDKNPYSFQ
SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR
850
3D view using mol* of 132_HIPK2_BRAF
PDB file >>>HKFP_193_HIPK2_BRAFENST00000406875ENST00000288602HIPK2chr7139297947BRAFchr7140449218
MAPVYEGMASHVQVFSPHTLQSSAFCSVKKLKIEPSSNWDMTGYGSHSKVYSQSKNIPLSQPATTTVSTSLPVPNPSLPYEQTIVFPGST
GHIVVTSASSTSVTGQVLGGPHNLMRRSTVSLLDTYQKCGLKRKSEEIENTSSVQIIEEHPPMIQNNASGATVATATTSTATSKNSGSNS
EGDYQLVQHEVLCSMTNTYEVLEFLGRGTFGQVVKCWKRGTNEIVAIKILKNHPSYARQGQIEVSILARLSTESADDYNFVRAYECFQHK
NHTCLVFEMLEQNLYDFLKQNKFSPLPLKYIRPVLQQVATALMKLKSLGLIHADLKPENIMLVDPSRQPYRVKVIDFGSASHVSKAVCST
YLQSRYYRAPEIILGLPFCEAIDMWSLGCVIAELFLGWPLYPGASEYDQIRYISQTQGLPAEYLLSAGTKTTRFFNRDTDSPYPLWRLKT
PDDHEAETGIKSKEARKYIFNCLDDMAQVNMTTDLEGSDMLVEKADRREFIDLLKKMLTIDADKRITPIETLNHPFVTMTHLLDFPHSTH
VKSCFQNMEICKRRVNMYDTVNQSKTPFITHVAPSTSTNLTMTFNNQLTTVHNQAPSSTSATISLANPEVSILNYPSTLYQPSAASMAAV
AQRSMPLQTGTAQICARPDPFQQALIVCPPGFQGLQASPSKHAGYSVRMENAVPIVTQAPGAQPLQIQPGLLAQAPEVIRMQDKNPYSFQ
SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR
850_HIPK2_BRAF


Top

Comparison of Fusion Protein Isoforms

check button Superimpose the 3D Structures Among All Fusion Protein Isoforms
* Download the pdb file and open it from the molstar online viewer.

check button Comparison of the Secondary Structures of Fusion Protein Isoforms

Top

Comparison of Fusion Protein Sequences/Structures with Known Sequences/Structures from PDB

HIPK2_BRAF does not have any known PDB structures.

Top

pLDDT score distribution

check button pLDDT score distribution of the predicted fusion protein structures from AlphaFold2
* AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100.
* The blue color at the bottom marks the best active site residues.
132_HIPK2_BRAF.png
all structure sitemap plddt 132_HIPK2_BRAF.png
132_HIPK2_BRAF.png
all structure sitemap plddt2 132_HIPK2_BRAF.png


Top

Potential Active Site Information


check button The potential binding sites of these fusion proteins were identified using SiteMap, a module of the Schrodinger suite.
Kinase Fusion AA seq ID in KinaseFusionDBSite scoreSizeDscoreVolumeExposureEnclosureContactPhobicPhilicBalanceDon/AccResidues

Top

Ramachandran Plot of Kinase Fusion Protein Structure


check button Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide.

132_HIPK2_BRAF_ramachandran.png
all structure HIPK2-BRAF

Top

Virtual Screening Results


check button Distribution of the average docking score across all approved kinase inhibitors.
Distribution of the number of occurrence across all approved kinase inhibitors.
5'-kinase fusion protein case
all structure HIPK2-BRAF
3'-kinase fusion protein case

Top

check button Drug information from DrugBank of the top 20 interacting small molecules.
* The detailed information of individual kinase inhibitors are available in the download page.
Fusion gene name infoDrugDocking scoreGlide g scoreGlide energy
132_HIPK2_BRAF-DOCK_HTVS_1-001Midostaurin-9.975389999999999-9.975389999999999-52.6901
132_HIPK2_BRAF-DOCK_HTVS_1-001Nilotinib-8.544889999999999-9.46969-61.0623
132_HIPK2_BRAF-DOCK_HTVS_1-001Nilotinib-8.544889999999999-9.46969-61.0623
132_HIPK2_BRAF-DOCK_HTVS_1-001Lapatinib-8.407680000000001-8.49648-69.9222
132_HIPK2_BRAF-DOCK_HTVS_1-001Sunitinib-8.38785-8.39205-45.8157
132_HIPK2_BRAF-DOCK_HTVS_1-001Lapatinib-8.30969-8.398489999999999-69.9326
132_HIPK2_BRAF-DOCK_HTVS_1-001Larotrectinib-7.639010000000001-7.639010000000001-45.7817
132_HIPK2_BRAF-DOCK_HTVS_1-001Palbociclib-7.59173-8.06123-49.5379
132_HIPK2_BRAF-DOCK_HTVS_1-001Palbociclib-7.59173-8.06123-49.5379
132_HIPK2_BRAF-DOCK_HTVS_1-001Palbociclib-7.59173-8.06123-49.5379
132_HIPK2_BRAF-DOCK_HTVS_1-001Binimetinib-7.5442-7.5529-49.7499
132_HIPK2_BRAF-DOCK_HTVS_1-001Binimetinib-7.5442-7.5529-49.7499
132_HIPK2_BRAF-DOCK_HTVS_1-001Selumetinib-7.53533-7.54403-51.0668
132_HIPK2_BRAF-DOCK_HTVS_1-001Selumetinib-7.53533-7.54403-51.0668
132_HIPK2_BRAF-DOCK_HTVS_1-001Vandetanib-7.40235-7.40235-45.0861
132_HIPK2_BRAF-DOCK_HTVS_1-001Nilotinib-7.39288-7.5324800000000005-53.9387
132_HIPK2_BRAF-DOCK_HTVS_1-001Nilotinib-7.39288-7.5324800000000005-53.9387
132_HIPK2_BRAF-DOCK_HTVS_1-001Lenvatinib-7.288880000000001-7.288880000000001-50.4615
132_HIPK2_BRAF-DOCK_HTVS_1-001Pralsetinib-7.2201699999999995-7.3116699999999994-56.4314
132_HIPK2_BRAF-DOCK_HTVS_1-001Cabozantinib-7.21853-7.26353-48.7133

Top

Kinase-Substrate Information of HIPK2_BRAF


check button Phosphorylation target of the kinase
(phosphosite, 03-17-2024)
KinaseKinase UniProt AccKinase speciesSubstrateSubstrate UniProt AccSubstrate phosphorylated residuesSubstrate phosphorylated sites (+/-7AA)Domain
BRAFP15056humanSLC9A1P19634T653LRsYNRHtLVADPyENEXCaM_BD
BRAFP15056humanEEF1A1P68104T88EtSkyyVtIIDAPGHGTP_EFTU
BRAFP15056humanBRAFP15056S465tVGQRIGsGsFGtVYPK_Tyr_Ser-Thr
BRAFP15056humanMAP2K1Q02750S222LIDsMANsFVGtRSYPkinase
BRAFP15056humanEEF1A2Q05639S21GHVDSGkstttGHLIGTP_EFTU
BRAFP15056humanMAP2K1Q02750S218VsGQLIDsMANsFVGPkinase
BRAFP15056humanTTKP33981S281VPVNLLNsPDCDVkt
BRAFP15056humanBADQ92934S99PFrGrsRsAPPNLWABcl-2_BAD
BRAFP15056humanMAP2K2P36507S222VsGQLIDsMANsFVGPkinase
BRAFP15056humanBADQ92934S75EIRsRHssyPAGtEDBcl-2_BAD
BRAFP15056humanNANOGQ9H9S0S68LIQDsPDsStsPKGK
BRAFP15056humanEEF1A1P68104S21GHVDSGkstttGHLIGTP_EFTU
BRAFP15056humanBRAFP15056S614SHQFEQLsGSILWMAPK_Tyr_Ser-Thr
BRAFP15056humanBADQ92934S118GRELRRMsDEFVDsFBcl-2_BAD
BRAFP15056humanBRAFP15056S467GQRIGsGsFGtVYkGPK_Tyr_Ser-Thr
BRAFP15056humanBRAFP15056T373APNVHINtIEPVNID
BRAFP15056humanMAP2K2P36507S226LIDsMANsFVGtRSYPkinase
BRAFP15056humanTTKP33981S436VFSVskQsPPIsTSk
BRAFP15056humanBADQ92934S134KGLPRPKsAGtAtQMBcl-2_BAD
HIPK2Q9H2X6humanHIPK2Q9H2X6T838SKRVKENtPPRCAMV
HIPK2Q9H2X6humanZBTB4Q9P1Z0T797ERPGGtPtPVIAYsK
HIPK2Q9H2X6humanKLF3P57682S78sPPsAGNsPSSLKFP
HIPK2Q9H2X6humanSIAH2O43255S68GGGAGPVsPQHHELT
HIPK2Q9H2X6humanHMGA1P17096T78ktrkttttPGrkPrG
HIPK2Q9H2X6humanHIPK2Q9H2X6S827SSSQAIssPQRSKRV
HIPK2Q9H2X6humanCTBP1Q13363S422AHPPHAPsPGQTVkP
HIPK2Q9H2X6humanPMLP29590S36PSEGRQPsPsPsPtE
HIPK2Q9H2X6humanTLE1Q04724S289DAsssPAstAsSASS
HIPK2Q9H2X6humanSIAH2O43255T119PTCRGALtPSIRNLA
HIPK2Q9H2X6humanMECP2P51608S216VkRVLEKsPGkLLVk
HIPK2Q9H2X6humanMECP2P51608S80AVPEAsAsPKQRRsI
HIPK2Q9H2X6humanTP53P04637S46AMDDLMLsPDDIEQWTAD2
HIPK2Q9H2X6humanSIRT1Q96EB6S682SDSGTCQsPSLEEPM
HIPK2Q9H2X6humanRUNX1Q01196S276VHPAtPIsPGRASGM
HIPK2Q9H2X6humanPMLP29590S8MEPAPARsPRPQQDP
HIPK2Q9H2X6humanEP300Q09472S2279PVQPNPMsPQQHMLP
HIPK2Q9H2X6humanHIPK2Q9H2X6T880QTIVIPDtPsPTVSV
HIPK2Q9H2X6humanCBX4O00257T497SLQVkPEtPASAAVA
HIPK2Q9H2X6humanHIPK2Q9H2X6Y361SkAVCstyLQsRYyRPkinase
HIPK2Q9H2X6humanKLF3P57682S108sPPIKKysPPsPGVQ
HIPK2Q9H2X6humanKLF3P57682S101GLsMPsssPPIKKys
HIPK2Q9H2X6humanTLE1Q04724S286LKkDAsssPAstAsS
HIPK2Q9H2X6humanCEBPBP17676S76HERAIDFsPyLEPLG
HIPK2Q9H2X6humanZBTB4Q9P1Z0T983AAPPAPPtPPPPTLP
HIPK2Q9H2X6humanHMGA1P17096S36PRkQPPVsPGtALVG
HIPK2Q9H2X6humanSIRT1Q96EB6S27ADREAAssPAGEPLR
HIPK2Q9H2X6humanHIPK2Q9H2X6S364VCstyLQsRYyRAPEPkinase
HIPK2Q9H2X6humanHDAC3O15379S374KMLNHAPsVQIHDVP
HIPK2Q9H2X6humanTP63Q9H3D4T491PQQRNALtPTTIPDG
HIPK2Q9H2X6humanHIPK2Q9H2X6S924SCVTVHDsPYSDSSS
HIPK2Q9H2X6humanRUNX1Q01196S249DTRQIQPsPPWsyDQ
HIPK2Q9H2X6humanTLE1Q04724S239KDSsHYDsDGDKsDD
HIPK2Q9H2X6humanKLF3P57682S250KRPLPVEsPDtQRKR
HIPK2Q9H2X6humanNOTCH1P46531T2511VPEHPFLtPsPEsPD
HIPK2Q9H2X6humanSIAH2O43255T26PPPQPQHtPsPAAPP
HIPK2Q9H2X6humanCTBP2P56545S428AHPSQAPsPNQPTKH
HIPK2Q9H2X6humanHMGA1P17096-2T67kTRkTTTtPGRkPrG
HIPK2Q9H2X6humanHIPK2Q9H2X6S848RCAMVHSsPACSTSV
HIPK2Q9H2X6humanPPM1DO15297S85PLPDAGAsPAPsRCCPP2C
HIPK2Q9H2X6humanRUNX1Q01196T273sPsVHPAtPIsPGRA
HIPK2Q9H2X6humanHIPK2Q9H2X6S934SDSSSNTsPYSVQQR
HIPK2Q9H2X6humanKLF3P57682S224PPLMNsVsPPQALLQ
HIPK2Q9H2X6humanKLF3P57682S111IKKysPPsPGVQPFG
HIPK2Q9H2X6humanHMGA1P17096T53kEPsEVPtPkRPrGr
HIPK2Q9H2X6humanKLF3P57682S71LTVNKRSsPPsAGNs
HIPK2Q9H2X6humanPPM1DO15297S54QPLPPRPsPAALPGG
HIPK2Q9H2X6humanHIPK2Q9H2X6S668GFQGLQAsPSkHAGY
HIPK2Q9H2X6humanCDKN1BP46527S10NVRVSNGsPsLErMD
HIPK2Q9H2X6humanHIPK2Q9H2X6S882IVIPDtPsPTVSVIT
HIPK2Q9H2X6humanZBTB4Q9P1Z0T795AAERPGGtPtPVIAY
HIPK2Q9H2X6humanELF4Q99607S369ASLELGPsLDEEIPT
HIPK2Q9H2X6humanCREB1P16220S257PGVVMAssPALPTQP
HIPK2Q9H2X6humanKLF3P57682S92PSSHRRAsPGLsMPs
HIPK2Q9H2X6humanPMLP29590S38EGRQPsPsPsPtERA
HIPK2Q9H2X6humanHMGA1P17096-2T42kEPsEVPtPkrPrGr
HIPK2Q9H2X6humanSIAH2O43255S28PQPQHtPsPAAPPAA
HIPK2Q9H2X6humanCEBPBP17676T235SsssPPGtPSPADAK
HIPK2Q9H2X6humanKLF3P57682S216DYYPEEMsPPLMNsV
HIPK2Q9H2X6humanSPASTQ9UBP0S268sGHHRAPsySGLSMV


check button Biological Network Integration of This Kinase and Substrates
(GeneMANIA website)

check button Enriched GO biological processes of the phosphorylation target genes of the kinase
KinaseGOIDGO termP.adjust
BRAFIDDescription0.00e+00
BRAFGO:0048679regulation of axon regeneration5.62e-05
BRAFGO:0030878thyroid gland development5.62e-05
BRAFGO:0035270endocrine system development5.62e-05
BRAFGO:0070570regulation of neuron projection regeneration5.62e-05
BRAFGO:0048538thymus development1.42e-04
BRAFGO:0031103axon regeneration1.42e-04
BRAFGO:0060324face development1.42e-04
BRAFGO:0031102neuron projection regeneration1.74e-04
BRAFGO:0050772positive regulation of axonogenesis3.79e-04
BRAFGO:0048678response to axon injury4.26e-04
BRAFGO:0060502epithelial cell proliferation involved in lung morphogenesis5.02e-04
BRAFGO:0060439trachea morphogenesis5.09e-04
BRAFGO:0048534hematopoietic or lymphoid organ development5.09e-04
BRAFGO:0033674positive regulation of kinase activity5.09e-04
BRAFGO:0048308organelle inheritance7.57e-04
BRAFGO:0048313Golgi inheritance7.57e-04
BRAFGO:0061684chaperone-mediated autophagy7.57e-04
BRAFGO:1903358regulation of Golgi organization8.17e-04
BRAFGO:0051347positive regulation of transferase activity8.44e-04
BRAFGO:0060438trachea development9.59e-04
BRAFGO:2000641regulation of early endosome to late endosome transport9.59e-04
BRAFGO:0010720positive regulation of cell development9.59e-04
BRAFGO:0050770regulation of axonogenesis1.21e-03
BRAFGO:1903034regulation of response to wounding1.55e-03
BRAFGO:0044342type B pancreatic cell proliferation1.85e-03
BRAFGO:0031099regeneration1.92e-03
BRAFGO:0002520immune system development2.09e-03
BRAFGO:1903649regulation of cytoplasmic transport2.16e-03
BRAFGO:0043550regulation of lipid kinase activity3.11e-03
BRAFGO:0050769positive regulation of neurogenesis3.35e-03
BRAFGO:0045022early endosome to late endosome transport3.60e-03
BRAFGO:0060428lung epithelium development3.60e-03
BRAFGO:0035987endodermal cell differentiation4.20e-03
BRAFGO:0098927vesicle-mediated transport between endosomal compartments4.20e-03
BRAFGO:0048009insulin-like growth factor receptor signaling pathway4.60e-03
BRAFGO:0051962positive regulation of nervous system development4.69e-03
BRAFGO:0060425lung morphogenesis4.69e-03
BRAFGO:0018105peptidyl-serine phosphorylation4.74e-03
BRAFGO:0001706endoderm formation5.11e-03
BRAFGO:0018209peptidyl-serine modification5.11e-03
BRAFGO:0046902regulation of mitochondrial membrane permeability5.41e-03
BRAFGO:0070371ERK1 and ERK2 cascade6.22e-03
BRAFGO:0048645animal organ formation6.22e-03
BRAFGO:0035019somatic stem cell population maintenance6.45e-03
BRAFGO:0006414translational elongation6.46e-03
BRAFGO:0071260cellular response to mechanical stimulus6.46e-03
BRAFGO:0010506regulation of autophagy6.46e-03
BRAFGO:0031346positive regulation of cell projection organization6.46e-03
BRAFGO:0090559regulation of membrane permeability6.84e-03

Top

Related Drugs to HIPK2_BRAF


check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

check button Distribution of the number of studies mentioning HIPK2-BRAF and kinase inhibitors the PubMed Abstract (04-01-2024)

Fusion gene - drug pair 1Fusion gene - drug pair 2PMIDPublication dateDOIStudy title

Top

Related Diseases to HIPK2_BRAF


check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Related diseases from the literature mentioned this fusion gene and drug.
(PubMed, 04-01-2024)
MeSH IDMeSH term

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneBRAFC0025202melanoma24CGI;CTD_human;UNIPROT
TgeneBRAFC1275081Cardio-facio-cutaneous syndrome14CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneBRAFC0009402Colorectal Carcinoma8CTD_human;UNIPROT
TgeneBRAFC0028326Noonan Syndrome8CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
TgeneBRAFC0238463Papillary thyroid carcinoma8CTD_human;ORPHANET
TgeneBRAFC0040136Thyroid Neoplasm6CGI;CTD_human
TgeneBRAFC0151468Thyroid Gland Follicular Adenoma6CTD_human
TgeneBRAFC0175704LEOPARD Syndrome6CLINGEN;GENOMICS_ENGLAND
TgeneBRAFC0549473Thyroid carcinoma6CGI;CTD_human
TgeneBRAFC3150970NOONAN SYNDROME 75CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneBRAFC0009404Colorectal Neoplasms4CTD_human
TgeneBRAFC3150971LEOPARD SYNDROME 34CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneBRAFC1519086Pilomyxoid astrocytoma3ORPHANET
TgeneBRAFC0004565Melanoma, B162CTD_human
TgeneBRAFC0009075Melanoma, Cloudman S912CTD_human
TgeneBRAFC0018598Melanoma, Harding-Passey2CTD_human
TgeneBRAFC0023443Hairy Cell Leukemia2CGI;ORPHANET
TgeneBRAFC0025205Melanoma, Experimental2CTD_human
TgeneBRAFC0033578Prostatic Neoplasms2CTD_human
TgeneBRAFC0152013Adenocarcinoma of lung (disorder)2CGI;CTD_human
TgeneBRAFC0376358Malignant neoplasm of prostate2CTD_human
TgeneBRAFC0587248Costello syndrome (disorder)2CLINGEN;CTD_human
TgeneBRAFC3501843Nonmedullary Thyroid Carcinoma2CTD_human
TgeneBRAFC3501844Familial Nonmedullary Thyroid Cancer2CTD_human


Top

Clinical Trials of the Found Drugs/Small Molecules


check button Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024)

check button Clinical Trials from clinicaltrials.gov (06-17-2024)

Fusion GeneKinase InhibitorNCT IDStudy StatusPhasesDisease# EnrolmentDate